Con l’evolvere delle conoscenze sul SARS-CoV-2 aumentano anche le risorse disponibili per un aggiornamento scientifico e professionale. Qui elenchiamo alcuni dei principali riferimenti specifici per l’ematologia.
Enti regolatori
FDA https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19
EMA https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19
AIFA https://www.aifa.gov.it/emergenza-covid-19
Società Scientifiche
ASH https://www.hematology.org/covid-19
EHA https://ehaweb.org/covid-19/
SIE http://www.siematologia.it/
ISTH ISTH International Society on Thrombosis and Hemostasis
IMS https://www.myelomasociety.org/
EuroBoodNet https://eurobloodnet.eu/covid-19/
Histiocyte Society https://www.histio.org/covid19
Fondazione Progetto Ematologia Raccomandazioni pratiche per il management dei pazienti con ITP durante l’emergenza COVID-19 (revisione gennaio 2021)
Editori e riviste
New England Journal of Medicine https://www.nejm.org/coronavirus
The Lancet https://www.thelancet.com/coronavirus
BJH Care of haematology patients in a COVID‐19 epidemic
Springer https://www.springernature.com/gp/researchers/campaigns/coronavirus
Elsevier https://www.elsevier.com/connect/coronavirus-information-center
Wiley https://novel-coronavirus.onlinelibrary.wiley.com/
Medrxiv (preprint server) https://www.medrxiv.org/
← Torna alla pagina di INSIEME